Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Nova Mentis Life Science Corp. C.LIB

Nova Mentis Life Science Corp is a Canadian-based company focused on building and supporting a diversified portfolio of health and wellness businesses. Through its subsidiary, the company is focused on exploring the anti-inflammatory effects of psilocybin in underexplored metabolic indications such as obesity and diabetes and providing a Health Canada Standard Licensed facility focused on the cultivation of AAAA premium, small batch, terpene rich dominant cultivars cured to perfection.


CSE:LIB - Post by User

Post by InvestorMDon May 02, 2018 12:41pm
60 Views
Post# 27970899

Bill C-45 - Third reading on or before June 7

Bill C-45 - Third reading on or before June 7The Senate committees studying Bill C-45 can recommend amendments to the bill. Those amendments will then be debated in the Senate chamber, and voted upon a third and final time. Under an agreed timetable released in January, the vote at third reading will be held "on or before June 7." If The Cannabis Act passes that third vote, the bill and its amendments will be sent back to the House of Commons for approval before receiving royal asset and becoming law.
<< Previous
Bullboard Posts
Next >>